Detalhe da pesquisa
1.
Immuno-toxicological evaluation of her1 cancer vaccine in non-human primates: a 6-month subcutaneous study.
Immunopharmacol Immunotoxicol
; 43(3): 283-290, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33722157
2.
Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies.
Front Oncol
; 12: 951267, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408164
3.
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.
Vaccine
; 40(13): 2068-2075, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35164986
4.
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine
; 40(31): 4220-4230, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691871
5.
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor.
Cancers (Basel)
; 12(9)2020 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847130
6.
HER1-based vaccine: Simultaneous activation of humoral and cellular immune response.
Semin Oncol
; 45(1-2): 75-83, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318087
7.
Ausencia de efectos de la terapia floral aplicada a adultos jóvenes con el fin de mejorar su memoria / Lack of effects of flower therapy applied to young adults to improve their memory function
Rev. cuba. invest. bioméd
; 28(4)oct.-dic. 2009. tab
Artigo
em Espanhol
| LILACS | ID: lil-616445